Cargando…

Pathogen-Specific Clinical Trials: A New Paradigm in Clinical Trials for Multidrug-Resistant Organisms

Detalles Bibliográficos
Autores principales:	Jorgensen, Sarah C. J., Rybak, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249180/ https://www.ncbi.nlm.nih.gov/pubmed/30284146 http://dx.doi.org/10.1007/s40121-018-0215-0

Ejemplares similares

Organ-on-chip: a new paradigm for clinical trials – correspondence
por: Chopra, Hitesh, et al.
Publicado: (2023)

Indian clinical trials: Paradigm shift from speed to quality?
por: Bhatt, Arun
Publicado: (2012)

Control of multidrug-resistant organisms
por: Raine, Richard
Publicado: (2019)

Editorial for Special Issue “Multidrug-Resistant Pathogens”
por: Koulenti, Despoina, et al.
Publicado: (2020)

Managed Clinical Networks: A New Paradigm for Clinical Medicine
por: Kunkler, Ian H
Publicado: (2000)

New Results Will Change the Paradigm for Phase I Trials and Drug Approval
por: Chabner, Bruce A.
Publicado: (2010)

New technology for detecting multidrug-resistant pathogens in the clinical microbiology laboratory.
por: Peterson, L R, et al.
Publicado: (2001)

Building clinical trial capacity to develop a new treatment for multidrug-resistant tuberculosis
por: Tupasi, Thelma, et al.
Publicado: (2016)

New clinical trial rules: Academic trials and tribulations
por: Bhatt, Arun
Publicado: (2019)

Susceptibility of multidrug resistant clinical pathogens to a chlorhexidine formulation
por: GÜNTHER, F., et al.
Publicado: (2015)

New Insights into Infections due to Multidrug Resistant Gram Negative Bacteria: The Interplay between Lab and Clinic
por: Oliva, Alessandra, et al.
Publicado: (2018)

New immunotherapeutic paradigms for castration-resistant prostate cancer
por: Galluzzi, Lorenzo
Publicado: (2013)

New mechanisms of multidrug resistance: an introduction to the Cancer Drug Resistance special collection
por: Gottesman, Michael M., et al.
Publicado: (2023)

Molecular and cellular paradigms of multidrug resistance in cancer
por: Vaidya, Foram U., et al.
Publicado: (2020)

Effectiveness of a Multicomponent Intervention to Reduce Multidrug-Resistant Organisms in Nursing Homes: A Cluster Randomized Clinical Trial
por: Mody, Lona, et al.
Publicado: (2021)

A New Vision for Clinical Trials in Africa
Publicado: (2004)

Clinical Pharmacology of Bacteriophage Therapy: A Focus on Multidrug-Resistant Pseudomonas aeruginosa Infections
por: Holger, Dana, et al.
Publicado: (2021)

Early clinical exposure: New paradigm in Medical and Dental Education
por: Verma, Mahesh
Publicado: (2016)

Clinical trials in cancer
por: Green, J A
Publicado: (2011)

What’s new in multidrug-resistant pathogens in the ICU?
por: Zilahi, Gabor, et al.
Publicado: (2016)

Special Issue: Emerging Paradigms in Insulin Resistance
por: Collier, J. Jason, et al.
Publicado: (2022)

Endo-hepatology: A new paradigm
por: Samarasena, Jason, et al.
Publicado: (2018)

The new Regulation on clinical trials in relation to radiopharmaceuticals: when and how will it be implemented?
por: Peñuelas, Iván, et al.
Publicado: (2019)

From blood development to disease: a paradigm for clinical translation
por: Justice, Monica J., et al.
Publicado: (2020)

Community-acquired Pneumonia Owing to Multidrug-Resistant Pathogens: A Step toward an Early Identification
por: Falcone, Marco, et al.
Publicado: (2021)

Phage Revolution Against Multidrug-Resistant Clinical Pathogens in Southeast Asia
por: Carascal, Mark B., et al.
Publicado: (2022)

Mutations in hmg1, Challenging the Paradigm of Clinical Triazole Resistance in Aspergillus fumigatus
por: Rybak, Jeffrey M., et al.
Publicado: (2019)

Translating Biospectroscopy Techniques to Clinical Settings: A New Paradigm in Point-of-Care Screening and/or Diagnostics
por: Martin, Francis L.
Publicado: (2023)

Isolation strategy for controlling the spread of multidrug-resistant organisms: Is this still an essential option in hospitals?
por: Larrosa, María Nieves, et al.
Publicado: (2021)

Isolation strategy for controlling the spread of multidrug-resistant organisms: Is this still an essential option in hospitals?
por: Larrosa, María Nieves, et al.
Publicado: (2021)

Simulators: a New Use for an Old Paradigm
por: Kavic, Michael S.
Publicado: (2006)

The multidrug-resistant PMEN1 pneumococcus is a paradigm for genetic success
por: Wyres, Kelly L, et al.
Publicado: (2012)

New paradigm in implant osseointegration
por: Joos, Ulrich, et al.
Publicado: (2006)

New Paradigms in Pharmaceutical Development
por: Cacabelos, Ramón
Publicado: (2022)

Trials and tribulations: obstacles to clinical trial recruitment
por: Reed, N, et al.
Publicado: (2003)

Clinical trials registration
por: Tiffin, Norman H, et al.
Publicado: (2013)

Standardization of clinical trials
por: Chander, N. Gopi
Publicado: (2017)

E-Clinical Trials: The Future of Clinical Trials and How Nurses Can Be Involved
por: Kapritsou, Maria
Publicado: (2020)

Spread of Multidrug-Resistant Microorganisms
por: Di Lodovico, Silvia, et al.
Publicado: (2022)

Pigeons as Carriers of Clinically Relevant Multidrug-Resistant Pathogens—A Clinical Case Report and Literature Review
por: Chrobak-Chmiel, Dorota, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cvg4utvs6gtqga9vnis2jph1og